164 related articles for article (PubMed ID: 15699121)
1. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model.
Ellmerich S; Mycko M; Takacs K; Waldner H; Wahid FN; Boyton RJ; King RH; Smith PA; Amor S; Herlihy AH; Hewitt RE; Jutton M; Price DA; Hafler DA; Kuchroo VK; Altmann DM
J Immunol; 2005 Feb; 174(4):1938-46. PubMed ID: 15699121
[TBL] [Abstract][Full Text] [Related]
2. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
[TBL] [Abstract][Full Text] [Related]
3. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
[TBL] [Abstract][Full Text] [Related]
4. Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis.
Ellmerich S; Takacs K; Mycko M; Waldner H; Wahid F; Boyton RJ; Smith PA; Amor S; Baker D; Hafler DA; Kuchroo VK; Altmann DM
Eur J Immunol; 2004 Jul; 34(7):1839-48. PubMed ID: 15214032
[TBL] [Abstract][Full Text] [Related]
5. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
Weissert R; Kuhle J; de Graaf KL; Wienhold W; Herrmann MM; Müller C; Forsthuber TG; Wiesmüller KH; Melms A
J Immunol; 2002 Jul; 169(1):548-56. PubMed ID: 12077287
[TBL] [Abstract][Full Text] [Related]
6. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
7. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
[TBL] [Abstract][Full Text] [Related]
8. Regulation of EAE by spontaneously generated IL-10-secreting regulatory T cells in HLA-DR15/TCR.Ob1A12 double transgenic mice.
Leno-Durán E; Ng SL; Strominger JL
Immunology; 2021 Jul; 163(3):338-343. PubMed ID: 33565605
[TBL] [Abstract][Full Text] [Related]
9. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
[TBL] [Abstract][Full Text] [Related]
10. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
[TBL] [Abstract][Full Text] [Related]
11. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
12. A human leucocyte antigen-DR1 transgene confers susceptibility to experimental allergic encephalomyelitis elicited by an epitope of myelin basic protein.
Sireci G; Dieli F; Caccamo N; Barera A; Carta P; Di Sano C; Meraviglia S; Bonanno CT; Salerno A
Scand J Immunol; 2003 Aug; 58(2):188-94. PubMed ID: 12869140
[TBL] [Abstract][Full Text] [Related]
13. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
14. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis.
Jones RE; Bourdette D; Moes N; Vandenbark A; Zamora A; Offner H
J Immunol; 2003 Feb; 170(4):1690-8. PubMed ID: 12574332
[TBL] [Abstract][Full Text] [Related]
15. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
16. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
[TBL] [Abstract][Full Text] [Related]
17. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis.
Dittel BN; Visintin I; Merchant RM; Janeway CA
J Immunol; 1999 Jul; 163(1):32-9. PubMed ID: 10384096
[TBL] [Abstract][Full Text] [Related]
18. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules.
Mycko MP; Waldner H; Anderson DE; Bourcier KD; Wucherpfennig KW; Kuchroo VK; Hafler DA
J Immunol; 2004 Aug; 173(3):1689-98. PubMed ID: 15265898
[TBL] [Abstract][Full Text] [Related]
20. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4.
Altmann DM; Douek DC; Frater AJ; Hetherington CM; Inoko H; Elliott JI
J Exp Med; 1995 Mar; 181(3):867-75. PubMed ID: 7532684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
